Navigation Links
Bradmer announces 2008 fourth quarter and fiscal year operational and financial results
Date:3/31/2009

has been, and is continuing to evaluate strategic options.

"We have successfully transitioned Neuradiab from a Phase II compound with compelling results at a single site to a cGMP manufactured compound in a multi-center Phase III trial under a rigorous protocol. We focused specifically on reducing risk in the critical areas of manufacturing, regulatory and clinical operations," said Alan M. Ezrin, Ph.D., President and Chief Executive Officer of Bradmer. "We have initiated enrollment of patients across multiple sites and demonstrated those sites are adhering to the protocol as designed. However, the delay we have experienced in the 60-patient run-in phase has placed significant pressure on our capital resources which necessitated the strategic review by the Board."

Financial Results

Amounts in US dollars, unless specified otherwise, and results expressed in accordance with Canadian Generally Accepted Accounting Principles (Canadian GAAP).

For the year ended December 31, 2008, Bradmer recorded a net loss of $11,529,000 or $0.85 per common share, compared to a net loss of $9,436,000 or $0.87 per common share for the year ended December 31, 2007. The increased loss in 2008 was primarily related to planned research and development spending with regard to the Corporation's lead clinical program, Neuradiab, in preparation for the Phase III clinical trial, as well as the growth in Bradmer's administrative functions in anticipation of the clinical trial launch.

Research and development expenses totaled $8,327,000 in fiscal 2008, compared to $7,256,000 in fiscal 2007. The increase was primarily due to increased compensation costs for the larger clinical staff amounting for $1,004,000 compared to $311,000 for 2007. The expenses incurred in 2008 for drug manufacturing contracts amounted to $3,351,000 compared to $3,970,000 in 2007. Amounts expensed to clinical research organizations were $2,350,000 in 2008, compared to $
'/>"/>

SOURCE Bradmer Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Bradmer implements cash conservation plan
2. Bradmer provides clinical trial update and announces evaluation of strategic alternatives
3. Bradmer to participate in panel presentation at RBC Capital Markets Healthcare Conference
4. Bradmer to present poster on progression free survival and overall survival data from Neuradiab(TM) Phase II trials at Society for Neuro-Oncology Meeting
5. Bradmer announces 2008 third quarter operational and financial results
6. Bradmer to present at Rodman & Renshaw Healthcare Conference
7. Bradmer receives FDA approval to proceed with Phase III clinical trial
8. Bradmer announces 2008 first quarter operational and financial results
9. Bradmer announces new additions to management team
10. Bradmer announces 2007 fourth quarter and fiscal year operational and financial results
11. Notice of Bradmer Pharmaceuticals Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/21/2014)... 21, 2014 Khanna Vision Institute is ... at the Aspen Helicopters holiday event for underprivileged kids. ... with sleigh, flown by an aspen helicopter pilot. In ... Santa with sleigh was visible.(please see accompanying video). Helicopter ... Dr.Khanna has helped many pilots with Pi in eye ...
(Date:12/21/2014)... HealthDay Reporter FRIDAY, Dec. 19, 2014 ... than traditional cigarettes, new research finds. Even though ... thousands of ex-smokers said they have fewer cravings and are ... to smoke, researchers reported. "The pattern was ... use than for tobacco use," said lead researcher Jonathan Foulds, ...
(Date:12/21/2014)... Serious Buyer, Andrew Hawley from Vintage Rock ... the Doors International Ballroom at the Hilton Hotel in ... only time that Morrison's mother would see her son ... According to Hawley, “This would be the Doors only ... Roller Rink earlier that year and would return to ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 Theme ... announced a new intro plugin for Final Cut Pro ... pictures, videos, logos, and more with absolute ease.” Said ... our users the tools needed to easily animate their ... Final Cut Pro X users to animate pictures, videos, ...
(Date:12/21/2014)... Concept Plus, LLC. a SDB and ... Fairfax, VA., today announced it has been recognized by ... which ranks the fastest growing government contracting small businesses by ... , This is the first year that Concept Plus, LLC., ... with a 95.92% compound annual growth rate. “For Concept Plus ...
Breaking Medicine News(10 mins):Health News:E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds 2Health News:E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds 3Health News:Announcing a new plugin for Final Cut Pro X ProMotion from Pixel Film Studios. 2Health News:Concept Plus, LLC. Named One of Washington Technology’s Fast 50 2
... a better choice, researchers say , , TUESDAY, Sept. 11 (HealthDay ... of diabetics to control blood sugar, greatly increases their risk ... drug does not up users, overall risk of death, however, ... benefits has shifted, and this needs to be factored into ...
... Provide New Levels of Protection, PITTSBURGH, Sept. ... leading developer of sophisticated safety equipment, today,announced that ... certified as meeting new rigorous performance requirements adopted,by ... M7 Air,Mask is the first device of its ...
... (Nasdaq: EMITF ) ("EMI") announced today that it had ... offering,of Series E Notes and Series F Notes in the ... be conducted in two separate tenders based on the,annual interest ... The Offering,Prospectus provides that the maximum interest rate of the ...
... 11, 2007 - A history of maternal epilepsy and ... later in life, says a new study published in ... Bergen and Norwegian Institute of Public Health, Bergen, Norway, ... with and without epilepsy, and found a correlation between ...
... Aviv Universitys Sackler School of Medicine is, quite simply, a ... of a small number of surgeons in the world who ... has developed a novel laser device that promises to revolutionize ... now, is expected to give most practicing eye surgeons the ...
... ... troops, PHOENIX, Sept. ... returning Guard members, TriWest Healthcare,Alliance, the Department of Defense,s TRICARE contractor in ... first Combat,Stress Video Conference. The conference, being held from 2 to 5 ...
Cached Medicine News:Health News:Diabetes Drug Avandia Boosts Heart Risks: Study 2Health News:Diabetes Drug Avandia Boosts Heart Risks: Study 3Health News:MSA's Next-Generation Breathing Apparatus for Firefighters First to Receive Full NFPA Approval 2Health News:MSA's Next-Generation Breathing Apparatus for Firefighters First to Receive Full NFPA Approval 3Health News:Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel 2Health News:Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel 3Health News:Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel 4Health News:Glaucoma surgery in the blink of an eye 2Health News:TriWest and Montana VA Launch PTSD Video Conference to Reach Rural Health Care Providers 2
(Date:12/19/2014)... WORTH, Texas , December 18, 2014 /PRNewswire/ ... a networked software application/module that is used to ... related images. RIS comprises a patient tracking and ... system. The integration of RIS with HIS and ... used for patient registration and patient scheduling, patient ...
(Date:12/19/2014)... REDWOOD CITY, Calif., Dec. 18, 2014 ... on the development of medical diagnostics based on ... of gas flow, today announced financial results for ... 30, 2014. "Following the completion of ... well positioned to maximize the recently initiated CoSense® ...
(Date:12/19/2014)... , Dec. 19, 2014  Eli Lilly and ... Paris: FR0011184241 – ADOC) today announced a worldwide licensing ... BioChaperone Lispro, for treatment in people with type 1 ... proprietary BioChaperone® technology and is currently in Phase Ib ... Lispro with the goal of optimizing glucose levels during ...
Breaking Medicine Technology:The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3
... , MORRISTOWN, N.J. , May 24 Watson ... subsidiary, Watson Laboratories, Inc., has received approval from the United States ... for Valacyclovir Hydrochloride tablets, USP, in the 500 and 1000 mg ... to begin shipping the product shortly.   , ...
... Genzyme Corp. has signed a consent decree agreeing to correct manufacturing quality violations at ... government $175 million in unlawful profits from the sale of products that ... , , ... , , ...
Cached Medicine Technology:Watson's Generic VALTREX® 500 mg and 1000 mg Receives FDA Approval 2Watson's Generic VALTREX® 500 mg and 1000 mg Receives FDA Approval 3Genzyme Corp. Signs Consent Decree to Correct Violations at Allston, Mass., Manufacturing Plant and Give up $175 Million in Profits 2Genzyme Corp. Signs Consent Decree to Correct Violations at Allston, Mass., Manufacturing Plant and Give up $175 Million in Profits 3
BD Vacutainer® Specialty Tubes - Trace Element - Plastic...
Inquire...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
BD Vacutainer® Plus Plastic Serum Tubes have spray-coated silica and are used for serum determinations in chemistry, serology, and immunohematology....
Medicine Products: